Patients may also be at risk for hyperperfusion with hypertension, which can lead to endothelial damage, cerebral edema, and intracranial hemorrhage, especially after the administration of intravenous tissue plasminogen activator (t-PA) or cerebral revascularization [21]. The gene discussed is PLAT; the disease is Hypertension.